Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Trans-N1-((1R,2S)-2-phenylcyclopropyl)cyclohexane-1,4-diamine bis-hydrochloride

EU orphan designation number: EU/3/13/1174   
Active ingredient: Trans-N1-((1R,2S)-2-phenylcyclopropyl)cyclohexane-1,4-diamine bis-hydrochloride
Indication: Treatment of acute myeloid leukaemia
Sponsor: Oryzon Genomics SA
C. Sant Ferran 74, E-08940 Cornella de Llobregat, Barcelona, Espaņa

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/08/2013 Centralised Orphan - Designation EMA/OD/064/13 (2013)5273 of 05/08/2013